Brands Cannabis Technology THC

PAX Labs Launches Inaugural PAX Pulse Exploring Cannabis Habits

Quarterly Survey Showcases Consumer Usage Trends and Preferences

SAN FRANCISCO–(BUSINESS WIRE)–PAX Labs, Inc., a leading consumer technology brand in cannabis, today announced the launch of its new PAX Pulse, a quarterly insights program highlighting consumer habits and preferences around cannabis consumption. The first survey conducted revealed increasing preferences for cannabis—whether to relax at the end of the day, elevate social experiences, or spice things up in the bedroom.

This poll was conducted by Ipsos and includes data from 2,700 total participants age 21 and over who have consumed cannabis within the past year in places where it has been legalized for adult use, including California, Colorado, Illinois, Massachusetts, Nevada, Oregon, Washington, and Canada.

The majority of cannabis users consume at least once a week.

61% of total respondents reported using cannabis at least once per week—including a majority of respondents across all age groups and geographic locations. Nineteen percent of respondents reported consuming several times each week and 32% reported consuming daily. Americans are more likely to consume cannabis daily than Canadians, with nearly two out of five Americans reporting daily consumption (37%), compared to a quarter of Canadians (27%).

People prefer to wind down with cannabis over alcohol.

Of those who consume cannabis, 79% prefer to wind down with cannabis—including both THC (67%) and CBD (12%) —whereas only 38% report a preference for alcohol and 17% for tobacco. Other studies show a decrease in alcohol consumption in places where cannabis is legal. Canadians are more likely to drink alcohol to relax at the end of the day than Americans—42% of Canadians report drinking alcohol is their ideal way to wind down, while only a third of Americans agree (33%).

Yes, sex is better with cannabis.

Approximately two-thirds (64%) say they like to share cannabis with a romantic partner often or sometimes. Those who don’t (18%) mostly say this is because they like to use cannabis, but their partner does not (15%). Among those who have been on a first date in the past year, 44% discuss their consumption with a potential partner after one date, and another one in five wait until going on two dates (20%). Of those who incorporate cannabis or cannabis-derived products in their sex lives (39%), the vast majority say they experience better sex when they do so (92%).

Not surprisingly, music enhances the cannabis experience.

Ninety percent of cannabis users enjoy listening to music while consuming cannabis. On average, cannabis users report listening to music half the time (48%) while under the influence of cannabis. Among those that report listening to music, the most popular genres of music to listen to while using cannabis are classic rock (50%) hip hop or rap (39%), pop music (36%), alternative rock/indie, and R&B/soul (32% each). Reggae (25%), metal and hard rock (25%), dance/electronic (23%), country (22%), and blues (20%) are also popular. In addition, about 40% of consumers say they have used cannabis before or while attending a music concert or festival in the past year.

About the Study

These are some of the findings of an Ipsos poll conducted between August 12-15, 2019. All qualified respondents are adults age 21+ who live in the US (n=1,200) or Canada (n=1,500). US respondents live in one of the following states: CA, NV, CO, OR, WA, MA. Sample is balanced to be reflective of the demographics of the target group for the given markets. All completes have used cannabis within the past year. The sample for this study was randomly drawn from Ipsos’ online panel (see link below for more info on “Access Panels and Recruitment”), partner online panel sources, and “river” sampling (see link below for more info on the Ipsos “Ampario Overview” sample method) and does not rely on a population frame in the traditional sense.

Statistical margins of error are not applicable to online non-probability polls. All sample surveys and polls may be subject to other sources of error, including, but not limited to coverage error and measurement error. The precision of Ipsos online polls is measured using a credibility interval. In this case, the poll has a credibility interval of plus or minus 2.2 percentage points for all respondents. The poll also has a credibility interval of plus or minus 3.2 percentage points for Americans and plus or minus 2.9 percentage points for Canadians.

About PAX Labs

PAX is a leader in the design and development of premium app-controlled vaporization technologies and devices. Headquartered in San Francisco, PAX has revolutionized the consumer experience through innovation and product design, and is committed to taking the guesswork out of cannabis with products that offer quality, safety and predictability. PAX has sold more than 500,000 Era devices for oil concentrates and over one million devices in the flower vaporizer category. PAX is committed to its mission: establishing cannabis as a force for good. For more information, please visit pax.com.

PAX Labs does not manufacture, produce or sell cannabis.

About Ipsos

Ipsos is the world’s third-largest market research company, present in 90 markets and employing more than 18,000 people. Our passionately curious research professionals, analysts and scientists have built unique multi-specialist capabilities that provide true understanding and powerful insights into the actions, opinions and motivations of citizens, consumers, patients, customers or employees. We serve more than 5000 clients across the world with 75 business solutions. Founded in France in 1975, Ipsos is listed on the Euronext Paris since July 1st, 1999. The company is part of the SBF 120 and the Mid-60 index and is eligible for the Deferred Settlement Service (SRD). ipsos.com

ISIN code FR0000073298, Reuters ISOS.PA, Bloomberg IPS:FP

Contacts

Megan Anderson
press@pax.com

SHARE
RELATED POSTS
Affordable Handheld Cannabis Testing Device
California cannabis industry braces for next phase of testing costs in 2019
A Cannabis Brand With Loads of Street Cred

Leave Your Reply

*